BioCentury
ARTICLE | Company News

Epimmune, BNRI HIV vaccine deal

November 29, 2001 8:00 AM UTC

EPMN and Bavarian Nordic (CSE:BNRI) partnered to design and develop therapeutic and prophylactic HIV vaccines. The deal combines EPMN's T cell epitope identification and vaccine design technologies wi...